http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107208148-B
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
filingDate | 2015-10-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2021-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate | 2021-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-107208148-B |
titleOfInvention | Method and kit for pathological grading of breast tumors |
abstract | The present disclosure is a method for identifying a tumor type in breast tissue of a subject. The method includes the steps of performing one or more nucleic acid-based assays for identifying mutations present in breast tissue obtained from a subject in accordance with a first test module and a second test module, each test module being associated with one or more The detection of at least one predetermined mutation in the plurality of genes is associated, and each test module is configured to provide a positive result corresponding to the detection of the at least one predetermined mutation in the tissue or corresponding to the absence of the detectable predetermined mutation in the sample a negative result; and identifying the type of tumor of the breast tissue based on the provided results of the first and second test modules. Preferably, the first test module is associated with the detection of MED12 gene mutation and/or RARA gene mutation, and the second test module is associated with the detection of FLNA gene mutation, SETD2 gene mutation and/or MLL2 gene mutation. |
priorityDate | 2015-01-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 187.